$45.84
0.661.46%
Last update: 12:56 PM
15 minutes delayed
Comments
Loading...
Ultragenyx Pharmaceutical
RARENASDAQ
Latest news for Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock
Ultragenyx Pharmaceutical Stock (NASDAQ: RARE)
Categories: All
Wednesday, July 24, 2024
Tuesday, July 23, 2024
Monday, July 22, 2024
Thursday, July 18, 2024
Wednesday, July 17, 2024
Thursday, June 27, 2024
Friday, June 14, 2024
Thursday, June 13, 2024
Wednesday, June 12, 2024
Tuesday, June 11, 2024
Thursday, June 06, 2024
Friday, May 31, 2024
- Wedbush Maintains Neutral on Ultragenyx Pharm...
- B of A Securities Maintains Buy on Ultragenyx...
- Canaccord Genuity Maintains Buy on Ultragenyx...
- Cantor Fitzgerald Maintains Overweight on Ult...
- Peeling Back The Layers: Exploring Ultragenyx Pharmaceutical Through Analyst Insights
- Stifel Maintains Buy on Ultragenyx Pharmaceut...
- Baird Maintains Outperform on Ultragenyx Phar...
Thursday, May 30, 2024
Wednesday, May 22, 2024
Monday, May 06, 2024
Friday, May 03, 2024
Thursday, May 02, 2024
Tuesday, April 30, 2024
Wednesday, April 24, 2024
Monday, April 22, 2024
Wednesday, April 17, 2024
Tuesday, April 16, 2024
Monday, April 15, 2024
- S&P 500 Down Over 1%; US Retail Sales Increase 0.7% In March
- Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- Crude Oil Down 1%; Charles Schwab Sales Top Estimates
- Rare Disease-Focused-Ultragenyx Pharmaceutical Stock Falls On Serious Adverse Events In Eaarly Genetic Disorder Study
- Ultragenyx shares are trading lower after the...
- Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
- Ultragenyx Reveal New Data From Phase 1/2 Stu...